Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational studyDamiano Baroncini, Angelo Ghezzi, Giuseppe Fenu et al.|Multiple Sclerosis Journal|2018Cited by 62
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre studyGiulia Mallucci, Roberto Bergamaschi, Pietro Annovazzi et al.|Journal of Neurology|2018Cited by 35